RecruitingNCT06595784

The HELlenic Thoracic Society Initiative for CΟPD and CVD

Sponsor

Hellenic Thoracic Society

Enrollment

900 participants

Start Date

Oct 15, 2024

Study Type

OBSERVATIONAL

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Cardiovascular Diseases (CVD)

Summary

COPD is one of the most common respiratory diseases in Greece, and maybe more than half a million Greek citizens suffer both from COPD and CVD, however their characteristics and management remain unknown. HELICOPD is a national, multicenter, prospective, non-interventional study designed to contribute to better understanding and depicting the demographic and clinical characteristics of this population, the COPD- and CVD-related adverse events in a two-years period, their quality of life and the healthcare resources use. The study is initiated and coordinated by the Hellenic Thoracic Society.

Eligibility

Min Age: 35 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This Greek study is observing patients who have both COPD (a chronic lung disease) and heart disease, to better understand how these two conditions progress together and affect each other over time. **You may be eligible if...** - You have been diagnosed with COPD - You also have at least one heart condition (such as heart failure, atrial fibrillation, atherosclerosis, or severe valve disease) - You are older than 35 years - You are willing to sign an informed consent form **You may NOT be eligible if...** - You do not have any heart disease alongside your COPD - You have a history of lung cancer - You have any other active cancer currently being treated - You have planned chest or abdominal surgery during the study - You are currently enrolled in another COPD intervention study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(2)

Department of Respiratory Medicine, Medical School, Democritus University of Thrace, University General Hospital

Alexandroupoli, Greece

5th Pulmonary Department, "Sotiria" Chest Diseases Hospital, Athens, Greece

Athens, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06595784

Related Trials

Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study

NCT073934121 location

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT075470981 location

Study of Patient With Frequent Exacerbations in Moscow

NCT073077811 location

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

NCT06878261268 locations

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

NCT06883305298 locations